UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012990
Receipt number R000015015
Scientific Title Association between reactive oxygen metabolites and severity of coronary artery disease and future cardiovascular events in coronary artery disease patients
Date of disclosure of the study information 2014/01/28
Last modified on 2015/02/01 22:36:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association between reactive oxygen metabolites and severity of coronary artery disease and future cardiovascular events in coronary artery disease patients

Acronym

Coronary artery disease and reactive oxygen merabolites

Scientific Title

Association between reactive oxygen metabolites and severity of coronary artery disease and future cardiovascular events in coronary artery disease patients

Scientific Title:Acronym

Coronary artery disease and reactive oxygen merabolites

Region

Japan


Condition

Condition

Coronary artery disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the relationship between reactive oxygen metabolites and severity of coronary artery disease in patient with coronary artery disease and to investigate the prognostic involvement of reactive oxygen metabolites in the future cardiovascular events in patients with coronary artery disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Composite endopoint of cardiovascular death, non-fatal myocardial infarction, unstable angina pectoris, non-fatal ischemic stroke, re-hospitalization for heart failure, or coronary revascularization

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with symptoms of angina or suspected myocardial ischemia, and who were examined the presence of coronary artery disease by coronary angiography in Kumamoto University Hospital.

Key exclusion criteria

Acute coronary syndrome
heart failure
Active infection diseases
History of malignancy
End stage of chronic kidney diseases
History of coronary artery bypass graft

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisao Ogawa

Organization

Graduate School of Medical Sciences, Kumamoto University

Division name

Department of Cardiovascular Medicine

Zip code


Address

1-1-1 Honjo, Kumamoto City, JAPAN

TEL

81-96-373-5175

Email

cvmhisho@kumamoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshihiro Hirata

Organization

Graduate School of Medical Sciences, Kumamoto University

Division name

Department of Cardiovascular Medicine

Zip code


Address

1-1-1 Honjo, Kumamoto City, JAPAN

TEL

81-96-373-5175

Homepage URL


Email

yyyyyoshi25@yahoo.co.jp


Sponsor or person

Institute

Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

Kumamoto University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 28 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Reactive oxygen metabolites was significantly higher in severe/complex coronary artery disease patients and correlated with the occurrence of future cardiovascular events.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 01 Month 10 Day

Date of IRB


Anticipated trial start date

2007 Year 01 Month 18 Day

Last follow-up date

2014 Year 02 Month 18 Day

Date of closure to data entry

2014 Year 03 Month 01 Day

Date trial data considered complete

2014 Year 03 Month 01 Day

Date analysis concluded

2014 Year 04 Month 01 Day


Other

Other related information

Patients were followed every month at the outpatient clinic until February 2014 or until an endpoint occured.


Management information

Registered date

2014 Year 01 Month 28 Day

Last modified on

2015 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015015


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name